Altered gyrification in chemotherapy‐treated older long‐term breast cancer survivors
Brain and Behavior · 2024
DOI: 10.1002/brb3.3634 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, 2024. Verfasst von Ebenezer Daniel und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, California, USA. Hauptthemen laut MEDLINE: Breast Neoplasms, Cancer Survivors, Magnetic Resonance Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, City of Hope Center for Cancer and Aging, NIA NIH HHS.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Purpose
The purpose of this prospective longitudinal study was to evaluate the changes in brain surface gyrification in older long‐term breast cancer survivors 5–15 years after chemotherapy treatment.
Methods
Older breast cancer survivors aged ≥ 65 years treated with chemotherapy (C+) or without chemotherapy (C‐) 5–15 years prior and age‐ and sex‐matched healthy controls (HC) were recruited (time point 1 (TP1)) and followed up for 2 years (time point 2 (TP2)). Study assessments for both time points included neuropsychological (NP) testing with the NIH Toolbox cognition battery and cortical gyrification analysis based on brain MRI.
Results
The study cohort with data for both TP1 and TP2 consisted of the following: 10 participants for the C+ group, 12 participants for the C‐ group, and 13 participants for the HC group. The C+ group had increased gyrification in six local gyral regions including the right fusiform, paracentral, precuneus, superior, middle temporal gyri and left pars opercularis gyrus, and it had decreased gyrification in two local gyral regions from TP1 to TP2 ( p < .05, Bonferroni corrected). The C‐ and HC groups showed decreased gyrification only ( p < .05, Bonferroni corrected). In the C+ group, changes in right paracentral gyrification and crystalized composite scores were negatively correlated ( R = –0.76, p = .01).
Conclusions
Altered gyrification could be the neural correlate of cognitive changes in older chemotherapy‐treated long‐term breast cancer survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Diagnostic Radiology, City of Hope National Medical Center, Duarte, California, USA.
- Department of Population Science, City of Hope National Medical Center, Duarte, California, USA.
- Department of Medical Oncology, City of Hope National Medical Center, Duarte, California, USA.
- Center for Cancer and Aging, City of Hope National Medical Center, Duarte, California, USA.
- Department of Supportive Care Medicine, City of Hope National Medical Center, Duarte, California, USA.
- Neurocognitive Research Lab, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
ORCID-Profile: Bihong T Chen
Förderung
- NCI NIH HHS
- City of Hope Center for Cancer and Aging
- NIA NIH HHS
- National Institutes of Health/
- National Institute on Aging
Zitieren
APA
Daniel, E., Deng, F., Patel, S. K., Sedrak, M. S., Kim, H., Razavi, M., Sun, C. L., Root, J. C., Ahles, T. A., Dale, W., & Chen, B. T. (2024). Altered gyrification in chemotherapy‐treated older long‐term breast cancer survivors. Brain and Behavior. https://doi.org/10.1002/brb3.3634
Vancouver
Daniel E, Deng F, Patel SK, Sedrak MS, Kim H, Razavi M, et al. Altered gyrification in chemotherapy‐treated older long‐term breast cancer survivors. Brain and Behavior. 2024. doi:10.1002/brb3.3634
BibTeX
@article{Daniel2024,
author = {Daniel, Ebenezer and Deng, Frank and Patel, Sunita K and Sedrak, Mina S and Kim, Heeyoung and Razavi, Marianne and Sun, Can-Lan and Root, James C and Ahles, Tim A and Dale, William and Chen, Bihong T},
title = {Altered gyrification in chemotherapy‐treated older long‐term breast cancer survivors},
journal = {Brain and Behavior},
year = {2024},
doi = {10.1002/brb3.3634}
}
EUVIMED